Good evening :)
Place Order
Add to Watchlist

Suven Pharmaceuticals Ltd

SUVENPHAR

Suven Pharmaceuticals Ltd

SUVENPHAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹17,183 cr, stock is ranked 308
Low RiskStock is 1.88x as volatile as Nifty
667.301.14% (-7.70)
667.301.14% (-7.70)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹17,183 cr, stock is ranked 308
Low RiskStock is 1.88x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹17,183 cr, stock is ranked 308
Low RiskStock is 1.88x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
39.799.900.89%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.585.120.70%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Suven Pharmaceuticals is engaged in Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue378.43900.121,077.691,453.711,386.691,356.66
Raw Materialssubtract124.52240.24310.32459.46430.08721.03
Power & Fuel Costsubtract18.0638.2444.2059.5573.93
Employee Costsubtract29.6365.1076.23100.48110.51
Selling & Administrative Expensessubtract16.2344.7644.9653.1855.25
Operating & Other expensessubtract17.8460.7091.0165.8496.66
Depreciation/Amortizationsubtract11.5023.5131.6439.1047.7348.63
Interest & Other Itemssubtract2.7923.0711.678.5312.815.34
Taxes & Other Itemssubtract48.5987.51105.34213.78148.44149.80
EPS24.9114.2317.8316.1616.96
DPS0.002.502.005.006.000.00
Payout ratio0.100.140.280.370.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Jun 8PDF
Feb 11PDF
Oct 30PDF
Aug 17PDF
FY 2022

Annual report

PDF

Investor Presentation

May 9PDF
May 9PDF
Feb 8PDF
+2 more
FY 2023

Annual report

PDF

Investor Presentation

Aug 8PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Suven Pharmaceuticals Ltd41.789.900.89%
Sun Pharmaceutical Industries Ltd34.864.980.93%
Cipla Ltd35.054.140.70%
Dr Reddy's Laboratories Ltd21.264.120.70%

Price Comparison

Compare SUVENPHAR with any stock or ETF
Compare SUVENPHAR with any stock or ETF
SUVENPHAR
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding60.00%12.15%1.98%10.01%15.85%

Dec 2022

Mar 2023

Jun 2023

Sep 2023

Shareholding History

JunSepDec '22MarJunSep8.49%7.58%8.11%9.47%9.50%10.01%

Mutual Funds Holding Trend

Increased Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 3.03%

Top 5 Mutual Funds holding Suven Pharmaceuticals Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
UTI Flexi Cap Fund - Growth - Direct Plan

Growth
1.7427%1.23%0.12%35/65 (+6)
Tata Small Cap Fund-Direct Plan-Growth

Growth
0.8332%2.33%0.19%13/66 (+24)
DSP Healthcare Fund - Direct - Growth

Growth
0.7805%7.81%1.93%4/29 (+2)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Suven Pharmaceuticals Ltd

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 9, 2022

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 9, 2022

Cash Dividend

Ex DateEx DateSep 9, 2022

Special
Special | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Sep 9, 2022

Cash Dividend

Ex DateEx DateMay 13, 2022

Interim 2
Interim 2 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

May 13, 2022

Cash Dividend

Ex DateEx DateMay 13, 2022

Special
Special | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

May 13, 2022

Cash Dividend

Ex DateEx DateFeb 15, 2022

Special
Special | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Feb 15, 2022